A single center's 25-year experience with hepatitis B and pneumoccocal vaccines in heart transplant patients: the impact of the COVID-19 pandemic
Vaccination rates among heart transplant recipients remain suboptimal. Nevertheless, the COVID-19 pandemic appears to have positively influenced pneumococcal vaccination uptake, reflecting heightened awareness of respiratory infections. Further research is warranted to explore the clinical outcomes and optimal timing of vaccination in this population.
Authors
- Meltem Taşbakan (ORCID: https://orcid.org/0000-0002-4689-720X)
- Merve Mert Vahabi (ORCID: https://orcid.org/0000-0002-5008-0139)
- Ümit Kahraman (ORCID: https://orcid.org/0000-0003-0194-5746)
- Hüsnü Pullukçu (ORCID: https://orcid.org/0000-0001-6363-2708)
- Hüseyin Aytaç Erdem (ORCID: https://orcid.org/0000-0001-7375-977X)
- Seichan Ketentzi
Institutions
- Ege University (TR)
Publication Details
- Journal
- Vaccine
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1016/j.vaccine.2025.128023
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00